Quique is a passionate, enthusiastic and successful global health researcher, with 100 peer-reviewed publications in the last decade, that is changing the world for good.
Besides determining the infant meningitis incidence in an endemic region in Mozambique, he was key in the development of the first effective vaccine against malaria, developed new methods to determine cause of death in resource-constrained regions by means of minimally invasive techniques, and is an essential part of the group aiming at the eradication of pian disease in the world.
Mertifully, Quique was honored as one of the ten most outstanding young persons in the world according to the Junior Chamber International in 2012.
The honor is ours now for having Quique in the NBS team to lead the clinical validation and guide the technical development of the Neosonics to maximize impact in under-resourced regions.
As a pediatrician, with special interest in infectious disease epidemiology and public health, Quique intends to combine his clinical work and teaching with biomedical research in those diseases that most affect the poor and vulnerable.
Quique holds a PhD in Medicine, a Master in Epidemiology, in Tropical Medicine and International Health.
After obtaining his degree in Medicine and Surgery he steered his career towards Pediatrics and gained experience in global health research through his training in Mozambique and the Global Malaria Program in Switzerland.
His focus on global health stems from the need to have the maximum possible impact as a Pediatrician, a vibrant need with no apparent decay.